GlassScriptPhysician profile
Scott A Woolf
NPI 1629509682
$3,806.35
in general payments reported to CMS, 2019-2025
14 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $981 · 2023: $1,023 · 2024: $951 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Honoraria: $38.86 · Gift: $26.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.72 |
| Honoraria | $38.86 |
| Gift | $26.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $936.64 | 2022-2025 | Hydrus Microstent, Clareon, Rocklatan |
| Abbvie INC. | $635.34 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Glaukos Corporation | $527.75 | 2022-2025 | Idosetr, Idose |
| Bausch & Lomb Americas INC. | $456.49 | 2022-2025 | Stellaris, Envista Mx60 Iol, Envista Envy Iol |
| New World Medical,INC. | $305.94 | 2022 | |
| Harrow Eye, LLC | $297.53 | 2025 | |
| Novartis Pharmaceuticals Corporation | $206.15 | 2022-2023 | |
| Rxsight INC | $146.71 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Biotissue Holdings INC. | $143.07 | 2025 | |
| Horizon Therapeutics Plc | $55.97 | 2023 | Tepezza |
| Sight Sciences, INC. | $37.05 | 2022 | |
| Allergan, INC. | $25.24 | 2022 | |
| Rayner Intraocular Lenses Limited | $18.96 | 2024 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Carl Zeiss Meditec USA, INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Woolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.